Union Square Park Capital Management's Strategic Acquisition of Eagle Pharmaceuticals Shares

Overview of the Recent Transaction On October 3, 2024, Union Square Park Capital Management, LLC (Trades, Porttolio) made a significant move in the pharmaceutical sector by aequiring 1,191,490 shares of Eagle Pharmaceuticals Inc (EGRX, Financial). This transaction marked a new holding for the firm, purchased at a price of $1.99 per share. The total investment impacted the firm's portfolio by 2.06%, establishing a substantial position in Eagle Pharmaceuticals, Located at 1251 Avenue of the Americas, New York ...